Sonnet BioTherapeutics, Inc. (SONN) is a biotechnology company with a focus on oncology. Its proprietary platform is targeted at biologic drugs of single or bispecific action. SONN has completed ...
PRINCETON, N.J., Sept. 25, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (“Sonnet” or the “Company”) (NASDAQ: SONN), a biopharmaceutical company developing innovative targeted ...
Sonnet BioTherapeutics (NASDAQ:SONN) will effect a 1-for-22 reverse stock split of its outstanding common stock, the company said Thursday. The reverse stock split will be effective as of the ...
Space to play or pause, M to mute, left and right arrows to seek, up and down arrows for volume. It is the first sonnet after the conclusion of the 'Procreation' opening sequence (Sonnets 1–17). See ...
PRINCETON, N.J. - Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: NASDAQ:SONN), a biopharmaceutical company specializing in the development of targeted biologic drugs, announced it will implement a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback